Blood test trial aims to Fine-Tune transplant care
Disease control
Terminated
This study tested whether using a special blood test (ImmuKnow®) to guide anti-rejection drug doses could improve outcomes for new kidney transplant patients. It aimed to see if this approach led to fewer serious infections or episodes of organ rejection compared to standard care…
Phase: PHASE4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC